RNA5S11: A Potential Drug Target and Biomarker (G100169762)

Target Name: RNA5S11

NCBI ID: G100169762

RNA5S11

Other Name(s): RNA, 5S ribosomal 11 | 5S rRNA 11 | RN5S11

RNA5S11: A Potential Drug Target and Biomarker

RNA5S11 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the T-cell receptor (TCR), which is a critical molecule in the immune system that plays a crucial role in fighting off infections and diseases. TCRs are composed of a constant region, a variable region, and a variable region that contains the binding sites for the TCR molecules. The variable region of TCRs contains the loop region, which is involved in the interactions between the TCR and the antigens.

RNA5S11 is a small RNA molecule that is expressed in all human tissues. It is a non-coding RNA molecule that contains 11 exons. It is located in the X chromosome and has a length of 1,120 base pairs. RNA5S11 is a potential drug target because it is involved in the regulation of the immune response. It is also a biomarker because it can be used to diagnose and monitor various diseases, including cancer, autoimmune diseases, and infections.

The Importance of RNA5S11

RNA5S11 is a critical regulator of the immune response. It is involved in the development and maintenance of T cells, which are the key immune cells that fight off infections and diseases. T cells are generated from hematopoietic stem cells (HSCs) and differentiate into two types: T cells and B cells. T cells are responsible for cell-mediated immunity, while B cells are responsible for producing antibodies as part of the humoral immune response.

RNA5S11 is a key regulator of the T-cell receptor (TCR). The TCR is a transmembrane protein that consists of a constant region, a variable region, and a variable region that contains the binding sites for the TCR molecules. The variable region of TCRs contains the loop region, which is involved in the interactions between the TCR and the antigens. RNA5S11 is a part of the TCR loop region and is involved in the regulation of the interactions between the TCR and antigens.

RNA5S11 is involved in the regulation of the cytoskeleton. The cytoskeleton is the structure that organizes the cells of the body and is involved in many cellular processes, including cell division, migration, and invasion. RNA5S11 is involved in the regulation of the cytoskeleton by interacting with the protein microtubule.

RNA5S11 is also involved in the regulation of the cell cycle. The cell cycle is the process by which cells grow, divide, and replicate their genetic material. RNA5S11 is involved in the regulation of the cell cycle by interacting with the protein kinesin.

Potential Therapeutic Applications

RNA5S11 has the potential to be a drug target for various diseases. One of the potential therapeutic applications of RNA5S11 is in the treatment of cancer. Cancer is a leading cause of death worldwide, and there is a need for new and more effective therapies to treat this disease. RNA5S11 may be a useful target for cancer because it is involved in the regulation of the immune response and has been shown to have anti-tumor effects in various cell lines and animal models.

RNA5S11 may also be

Protein Name: RNA, 5S Ribosomal 11

The "RNA5S11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5S11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets